References
- Dinjens WNM, van Leerdam ME, Wagner A. On the advent of MSI testing of all colorectal cancers and a substantial part of other Lynch syndrome-related neoplasms. Expert Rev Mol Diagn 2010;10:381–4.
- Van Lier MG, de Wilt JH, Wagemakers JJ, Dinjens WN, Damhuis RA, Wagner A, Underutilization of microsatellite instability analysis in colorectal cancer patients at high risk for Lynch syndrome. Scand J Gastroenterol 2009;44:600–4.
- Mecklin JP. Frequency of hereditary colorectal carcinoma. Gastroenterology 1987;93:1021–5.
- Ponz de Leon M, Sassatelli R, Sacchetti C, Zanghieri G, Scalmati A, Roncucci L, Familial aggregation of tumors in the three-year experience of a population-based colorectal cancer registry. Cancer Res 1989;49:4344–8.
- Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P, Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med 2005;352:1851–60.
- Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P, Feasibility of screening for Lynch syndrome among patients with colorectal cancer. J Clin Oncol 2008;26:5783–8.
- Lynch HT, de La Chapelle A. Hereditary colorectal cancer. N Engl J Med 2003;348:919–32.
- Vasen HF, Möslein G, Alonso A, Bernstein I, Bertario L, Blanco I, Guidelines for the clinical management of Lynch syndrome (hereditary nonpolyposis colorectal cancer). J Med Genet 2007;44:353–62.
- Alexander J, Watanabe T, Wu TT, Rashid A, Li S, Hamilton SR. Histopathological identification of colon cancer with microsatellite instability. Am J Clin Pathol 2001;158:527–35.
- Greenson JK, Bonner JD, Ben-Yzhak O, Greenson JK, Bonner JD, Ben-Yzhak O, Phenotype of microsatellite unstable colorectal carcinomas: well differentiated and focally mucinous tumors and the absence of dirty necrosis correlate with microsatellite instability. Am J Surg Pathol 2003;27:563–70.
- Greenson JK, Huang S-C, Herron C, Moreno V, Bonner JD, Tomsho LP, Pathologic predictors of microsatellite instability in colorectal cancer. Am J Surg Pathol 2009:33:126–133.
- Halvarrson B, Anderson H, Domanska K, Lindmark G, Nilbert M. Clinicopathologic factors identify sporadic mismatch repair-defective colon cancers. Am J Clin Pathol 2008;129:238–44.
- Román R, Verdū M, Calvo M, Vidal A, Sanjuan X, Jimeno M, Microsatellite instability of the colorectal carcinoma can be predicted in the conventional pathologic examination. A prospective multicentric study and the statistical analysis of 615 cases consolidate our previously proposed logistic regression model. Virchows Arch 2010;456:533–41.
- Järviven HJ, Aarnio M, Mustonen H, Aktan-Collan K, Aaltonen LA, Peltomäki P, Controlled 15-year trial on screening for colorectal cancer in families with hereditary non-polyposis colorectal cancer. Gastroenterology 2000;118:829–34.
- de Jong AE, Hendriks YM, Kleibeuker JH, de Boer SY, Cats A, Griffioen G, Decrease in mortality in Lynch syndrome families because of surveillance. Gastroenterology 2006;130:665–71.
- Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, Rüschoff J, Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004;96:261–8.
- Gologan A, Krasinskas A, Hunt J, Thull DL, Farkas L, Sepulveda AR. Performance of the revised Bethesda guidelines for identification of colorectal carcinomas with a high level of microsatellite instability. Arch Pathol Lab Med 2005;129:1390–7.
- Bacher JW, Flanagan LA, Smalley RL, Nassif NA, Burgart LJ, Halberg RB, Development of a fluorescent multiplex assay for detection of MSI-High tumors. Dis Markers 2004;20:237–50.
- Esemuede I, Forslund A, Khan SA, Improved testing for microsatellite instability in colorectal cancer using a simplified 3-marker assay. Ann Surg Oncol 2010;17:3370–8.
- Mvundura M, Grosse SD, Hampel H, The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer. Genet Med 2010;12:93–104.
- Samowitz WS, Curtin K, Ma KN, Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level. Cancer Epidemiol Biomarkers Prev 2001;10:917–23.
- Evaluation of genomic applications in practice and prevention (EGAPP) working group. Recommendations from the EGAPP working group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genet Med 2009;11:35–41.